These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6096843)

  • 21. [Electroencephalographic study during long-term use of nicergoline].
    Miletto D; Julou M
    Ann Med Psychol (Paris); 1976 Dec; 134(5):824-31. PubMed ID: 1026140
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinico-rheographic study of the cerebrovascular effect of alpha-adrenergic blockers in vascular diseases of the brain].
    Shtok VN; Varlamova IV; Fedorova NV; Timurbaator
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(9):1333-8. PubMed ID: 4072531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nicergoline in the treatment of neuropathic bladder dysfunction: a preliminary report.
    Gallego J; Forner V; Jimenez F; Martinez E
    Paraplegia; 1984 Aug; 22(4):216-24. PubMed ID: 6483464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical and rheographic results of nicergoline in the treatment of arteritis of the lower extremities].
    Schrub JC; Courtois H; Philippe JC; Boismare F
    Therapie; 1975; 30(3):407-15. PubMed ID: 1224362
    [No Abstract]   [Full Text] [Related]  

  • 25. [Trial of nicergoline in arteriopathies of the lower limbs (apropos of 33 cases)].
    Debaert M; Ribet M; Quandalle P
    Lille Med; 1981 Mar; 26(3):140-3. PubMed ID: 7289750
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of nicergoline on cerebral blood flow.
    Iliff LD; Du Boulay GH; Marshall J; Russell RW; Symon L
    J Neurol Neurosurg Psychiatry; 1977 Aug; 40(8):746-7. PubMed ID: 925694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Use of nicergoline (IDB-1076) in the treatment of mild to moderate systemic arterial hypertension in adults and in the aged].
    Rinaldi G; Nieri A; Saponati G
    Minerva Cardioangiol; 1987 Oct; 35(10):573-83. PubMed ID: 3438004
    [No Abstract]   [Full Text] [Related]  

  • 28. [Therapeutic efficacy of nicergoline in ophthalmology. Fluorescence retinographic study (author's transl)].
    Borgioli M; Merendino E; Ricci B
    Arzneimittelforschung; 1979; 29(8a):1311-6. PubMed ID: 540076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cerebrovascular disorders : facial thermography as a means to evaluate the therapeutic effectiveness of nicergoline].
    Sbarbaro V; Zardini GB; Morgante R; Mora L; Acciarri L; Pistolesi GF
    Farmaco Prat; 1976 Nov; 31(11):549-60. PubMed ID: 1017468
    [No Abstract]   [Full Text] [Related]  

  • 30. [Controlled study with nicergoline and placebo in cerebral and peripheral vascular insufficiency in the aged].
    Cascone A; Liverta C; Pollini C
    Minerva Cardioangiol; 1978; 26(1-2):95-100. PubMed ID: 347330
    [No Abstract]   [Full Text] [Related]  

  • 31. [Failure of nicergoline to control blood pressure in surgery of pheochromocytoma].
    Pinaud M; Arnould JF; Le Neel JC; Rodat O
    Ann Fr Anesth Reanim; 1983; 2(4):327-8. PubMed ID: 6650937
    [No Abstract]   [Full Text] [Related]  

  • 32. [Value of nicergoline in postischemic cerebral resuscitation. An experimental study in the dog].
    Cahn R; Weber S; Angignard J; Angignard D; Borzeix MG
    Agressologie; 1987 Mar; 28(3):341-6. PubMed ID: 3618895
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical and biochemical effects of nicergoline in chronic schizophrenic patients.
    Albus M; Botschev C; Müller-Spahn F; Naber D; Münch U; Ackenheil M
    Pharmacopsychiatry; 1986 May; 19(3):101-5. PubMed ID: 3725889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Importance of improving sympathetic tonus in the medical treatment of impotence with vascular disorders: clinical and ultrasonic study of the action of nicergoline].
    Chomant J; de Somer-Leroy R; Boismare F; Boquet J; Ozenne G; Schrub JC
    LARC Med; 1982 Sep; 2(8):717-9. PubMed ID: 7162273
    [No Abstract]   [Full Text] [Related]  

  • 35. [Neurophysiological study of 36 patients with cerebral vascular processes treated with nicergoline (author's transl)].
    Samsó Dies JM; Villa Badó J; Villalobos J; Iriarte JL; Ordeix R
    Arzneimittelforschung; 1979; 29(8a):1301-7. PubMed ID: 540075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Interaction between anti-aggregating and anticoagulant agents. A double blind study on the concomitant administration of nicergoline and acenocoumarols].
    Pogliani E; Recalcati P; Tantalo V; Bregnani P
    Arzneimittelforschung; 1979; 29(8a):1266-9. PubMed ID: 395954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Nicergoline and steal effect in favor of zones of hypoperfusion in cerebral ischemic accidents].
    Philippon BL; Thivolle P; Berger M
    Rev Electroencephalogr Neurophysiol Clin; 1982 Dec; 12(4):361-6. PubMed ID: 7170383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Evidence for an alpha 2-blocking property of nicergoline by using antilipolytic alpha-adrenoceptors from adipose tissue].
    Carpéné C; Lafontan M; Berlan M
    J Pharmacol; 1983; 14(1):57-66. PubMed ID: 6132024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Animal model of anxiety: effect of nicergoline in the genetically hypertensive rats of Koletsky type and in the rats of Wistar strain.
    Golda V; Petr R
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1989; 32(1):109-20. PubMed ID: 2799259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Therapeutic trial in acute cochlear deafness. A comparative study of Ginkgo biloba extract and nicergoline].
    Dubreuil C
    Presse Med; 1986 Sep; 15(31):1559-61. PubMed ID: 2947099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.